Filing Details
- Accession Number:
- 0000849146-20-000091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-17 19:56:06
- Reporting Period:
- 2020-06-17
- Accepted Time:
- 2020-06-17 19:56:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 849146 | Lifevantage Corp | LFVN | Pharmaceutical Preparations (2834) | 841097796 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642848 | Jay Darren Jensen | 9785 South Monroe Street, Suite 400 Sandy UT 84070 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-06-17 | 4,500 | $14.41 | 480,585 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2019.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.11 to $14.65, inclusive.The reporting person undertakes to provide to LifeVantage Corporation, any security holder of LifeVantage Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
